Haner Direskeneli
Haner Direskeneli
Marmara University, School of Medicine, Division of Rheumatology, Istanbul, Turkey
Verified email at marmara.edu.tr
Title
Cited by
Cited by
Year
Immunosuppressive therapy in lupus nephritis: the Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide
FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ER Garrido, ...
Arthritis & Rheumatism 46 (8), 2121-2131, 2002
10822002
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative
B Dasgupta, MA Cimmino, HM Kremers, WA Schmidt, M Schirmer, ...
Arthritis & Rheumatism 64 (4), 943-954, 2012
6832012
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
C Dejaco, S Ramiro, C Duftner, FL Besson, TA Bley, D Blockmans, ...
Annals of the rheumatic diseases 77 (5), 636-643, 2018
5202018
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide
FA Houssiau, C Vasconcelos, D D’Cruz, GD Sebastiani, ...
Annals of the rheumatic diseases 69 (01), 61-64, 2010
4752010
Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51
H Direskeneli
Annals of the rheumatic diseases 60 (11), 996-1002, 2001
4512001
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial
FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ...
Arthritis & rheumatism 50 (12), 3934-3940, 2004
4082004
Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder?
H Direskeneli
Rheumatology 45 (12), 1461-1465, 2006
1952006
Takayasu's arteritis in Turkey—clinical and angiographic features of 248 patients
M Bicakcigil, K Aksu, S Kamali, Z Ozbalkan, A Ates, O Karadag, HTE Ozer, ...
Clinical & Experimental Rheumatology 27 (1), S59, 2009
1922009
Management of Takayasu arteritis: a systematic review
G Keser, H Direskeneli, K Aksu
Rheumatology 53 (5), 793-801, 2014
1912014
Oral health related quality of life is affected by disease activity in Behçet's disease
G Mumcu, N Inanc, T Ergun, K Ikiz, M Gunes, U Islek, S Yavuz, H Sur, ...
Oral diseases 12 (2), 145-151, 2006
1712006
The role of heat shock proteins in Behcet's disease
H Direskeneli, G Saruhan-Direskeneli
Clinical and Experimental Rheumatology 21 (4; SUPP/30), S44-S48, 2003
1692003
MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement
P Atagunduz, T Ergun, H Direskeneli
Clinical and experimental rheumatology 21 (4; SUPP/30), S35-S37, 2003
1622003
Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis
N Inanc, E Dalkılıc, S Kamalı, E Kasapoglu-Günal, Y Elbir, H Direskeneli, ...
Clinical rheumatology 26 (1), 17-23, 2007
1582007
'MHC-I-opathy'—unified concept for spondyloarthritis and Behçet disease
D McGonagle, SZ Aydin, A Gül, A Mahr, H Direskeneli
Nature Reviews Rheumatology 11 (12), 731-740, 2015
1542015
Identification of multiple genetic susceptibility loci in Takayasu arteritis
G Saruhan-Direskeneli, T Hughes, K Aksu, G Keser, P Coit, SZ Aydin, ...
The American Journal of Human Genetics 93 (2), 298-305, 2013
1502013
Neutrophil activation in Behçet's disease
E Eksioglu-Demiralp, H Direskeneli, A Kibaroglu, S Yavuz, T Ergun, ...
Clinical and experimental rheumatology 19 (5; SUPP/24), S-19, 2001
1442001
Oral health is impaired in Behçet's disease and is associated with disease severity
G Mumcu, T Ergun, N Inanc, I Fresko, T Atalay, O Hayran, H Direskeneli
Rheumatology 43 (8), 1028-1033, 2004
1402004
Identification of novel genetic susceptibility loci for Behçet's disease using a genome-wide association study
Y Fei, R Webb, BL Cobb, H Direskeneli, G Saruhan-Direskeneli, ...
Arthritis research & therapy 11 (3), 1-7, 2009
1372009
Identification of multiple independent susceptibility loci in the HLA region in Behcet's disease
T Hughes, P Coit, A Adler, V Yilmaz, K Aksu, N Düzgün, G Keser, A Cefle, ...
Nature genetics 45 (3), 319-324, 2013
1352013
Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial
D van der Heijde, R Landewé, R van Vollenhoven, S Fatenejad, ...
Annals of the rheumatic diseases 67 (9), 1267-1270, 2008
134*2008
The system can't perform the operation now. Try again later.
Articles 1–20